We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Western Blotting Detection Kit

By Biotechdaily staff writers
Posted on 07 Oct 2002
A new Western Blotting Detection Kit is designed to enable scientists to visualize and identify proteins that previously went undetected due to their low concentrations.

Called ECL Advance, the kit contains the highest sensitivity chemiluminescent substrate available for the detection of immobilized protein, says the marketer, Amersham Biosciences (Little Chalfont, UK). ECL Advance is a proprietary new substrate licensed exclusively to Amersham by Lumigen, Inc. (Southfield, MI, USA). A feature called Advance Blocking Agent controls backgrounds and ensures a high level of signal intensity. Antibody concentrations can also be reduced to previously unmatched levels, allowing stocks of these potentially valuable preparations to be conserved.

‘With optimized reagents, ECL Advance offers both the highest sensitivity chemiluminescent Western blotting and the ability to reduce the concentration of antibody, thereby saving on the cost and supply of these valuable resources,” said Pieter Noordeloos, vice president marketing, proteomics, Amershambiosciences. The company says the ECL Advance is up to 10 times more sensitive than other chemiluminescent Western Blotting detection kits.




Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Automated Clinical Chemistry Analyzer
Envoy 500+
New
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group

Latest BioResearch News

Study Identifies Protein Changes Driving Immunotherapy Resistance in Multiple Myeloma
07 Oct 2002  |   BioResearch

Genetic Analysis Identifies BRCA-Linked Risks Across Multiple Cancers
07 Oct 2002  |   BioResearch

Study Identifies Hidden B-Cell Mutations in Autoimmune Disease
07 Oct 2002  |   BioResearch